Business Context and Reporting Period
Company: cbdMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 16, 2022
Reporting Period: Specific event date of March 16, 2022.
Business Overview: The registrant is an emerging growth company incorporated in North Carolina, trading common stock (YCBD) and 8.0% Series A Cumulative Convertible Preferred Stock (YCBDpA) on the NYSE American.
Key Financial Metrics
This filing does not contain comprehensive financial statements. The only specific financial metric disclosed is the declaration of a cash dividend.
- Dividend Declaration: $0.0667 per share of 8.0% Series A Cumulative Convertible Preferred Stock.
- Record Date: April 1, 2022.
- Payment Date: April 15, 2022.
Note: The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing reports a specific corporate action rather than a change in financial performance compared to a prior period. The material event is the declaration of the monthly cash dividend for the Series A Convertible Preferred Stock.
Guidance, Outlook, and Risks
Management Commentary: The filing is limited to the formal declaration of the dividend and does not include forward-looking guidance, strategic outlook, or management discussion of operations.
Risks and Contingencies: No specific risks or contingencies are detailed in this document beyond the standard obligations of the preferred stock dividend payment.
Key Facts for Investor Verification
- Verify the record date (April 1, 2022) to determine eligibility for the $0.0667 per share dividend.
- Confirm the payment date of April 15, 2022, for cash flow planning.
- Review the terms of the 8.0% Series A Cumulative Convertible Preferred Stock to understand the cumulative nature of the dividend obligation.
- Check subsequent filings for the actual payment of the declared dividend.